Intelligence · Clinical Development
Pipeline search results
Programs matching “schizophrenia” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 97 pipeline programs matching "schizophrenia" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
NMDAE
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prodromal Schizophrenia
1 trial -
NMDAE
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Schizophrenia
2 trials -
NMDAE plus AIFA
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Schizophrenia
1 trial -
OPC-34712
Otsuka Beijing Research Institute
Schizophrenia
1 trial -
OXY-APS
The George Institute
schizophrenia or other primary psychotic disorders (SSD)
1 trial -
Pimavanserin 34 milligrams (MG) [Nuplazid]
Acadia Pharmaceuticals B.V.
Schizophrenia
1 trial -
Placebo
Jazz Pharmaceuticals Ireland Limited
Schizophrenia
1 trial -
Placebo
MapLight Therapeutics
Schizophrenia
1 trial -
RP5063
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Acute Schizophrenia
1 trial -
Rimonabant
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Risperidone
Indivior Pty Ltd
Schizophrenia
1 trial -
S1RA plus NMDAE
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Schizophrenia
1 trial -
SPD489 (lisdexamfetamine dimesylate)
Takeda
Schizophrenia and Predominant Negative Symptoms
1 trial -
Sarcosine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Schizophrenias
1 trial -
Sarcosine and D-serine
Hospital Authority, Hong Kong
Schizophrenias
1 trial -
Sodium Oxybate
Jazz Pharmaceuticals Ireland Limited
Schizophrenia
1 trial -
TAK-041
NEUROCRINE BIOSCIENCES INC
Stable Schizophrenia
1 trial -
TAK-063 20 mg
Takeda
Schizophrenia
1 trial -
armodafinil
Teva Pharma GmbH
Schizophrenia
2 trials -
mutual support group
Hong Kong Baptist University
Schizophrenia
1 trial -
sarcosine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Schizophrenia
1 trial -
BXCL501 80 Micrograms
BioXcel Therapeutics
Schizophrenia
1 trial -
Dronabinol
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
ITI-214 Dose A
Takeda
Schizophrenia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.